|Event Time:||Monday May 6, 2019 11:30 am to 6:30 pm|
|Topic(s):||Neuro Trauma, Critical Care, and Sports Neurology, General Neurology, Aging, Dementia, Cognitive, and Behavioral Neurology, Autoimmune Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, Epilepsy/Clinical Neurophysiology (EEG), Global Health, Headache, Movement Disorders, MS and CNS Inflammatory Disease, Neuromuscular and Clinical Neurophysiology (EMG), Neuro-oncology, Pain and Palliative Care, Research Methodology, Education, and History|
|Currently there are no events in the timeline.|
|Cerebrovascular Disease and Interventional Neurology ePoster Session|
|11:30 AM||001||Metformin Use and Stroke Risk in Hispanic and Non-Hispanic Diabetic Male Veterans||
Dr. Vasquez has nothing to disclose.
|Headache Clinical Trials II|
|11:30 AM||001||Impact of Fremanezumab on Response Rates, Acute Medication Use, and Disability in Patients With Episodic Migraine Who Have Failed at Least One Prior Migraine Preventive Medication||
Dr. Winner has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Allergan, Amgen, Supernus, Teva, Novartis, Avanir, and Promius.
|11:30 AM||001||Incidence and trends of Frontotemporal Disorders in Olmsted County: a population based study (1995-2010).||
Dr. Turcano has nothing to disclose.
|Autoimmune and Paraneoplastic Encephalitis|
|11:30 AM||001||Quantifying CSF Biomarkers of Neuronal Injury, Neuroinflammation and Synaptic Integr|